Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic PDAC
Arndt Vogel, Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School, shared a recent article by Ethan B. Ludmir on X:
“Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma at Journal of Clinical Oncology.”
Authors: Ethan B. Ludmir, Alexander D. Sherry, Bryan M. Fellman, Suyu Liu, Tharakeswara Bathala, Cara Haymaker, Marina N. Medina-Rosales, Alexandre Reuben, Emma B. Holliday, Grace L. Smith, Sonal S. Noticewala, Sarah Nicholas, Tracy R. Price, Rachael M. Martin-Paulpeter, Luis A. Perles, Sunyoung S. Lee, Michael S. Lee, Brandon G. Smaglo, Ryan W. Huey, Jason Willis, Dan Zhao, Lorenzo Cohen, Cullen M. Taniguchi, Eugene J. Koay, Matthew H.G. Katz, Robert A. Wolff, Prajnan Das, Shubham Pant, Albert C. Koong, and Chad Tang.
Arndt Vogel, MD, is a Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. Leading the GICancer Center and the Center for Personalized Medicine, his research focuses on translational and clinical studies in gastrointestinal cancer. He’s actively engaged in various societies including ESMO, ASCO, and EASL. Additionally, he chairs the Hepatobiliary Cancer Study Group of the AIO, contributing significantly to clinical oncology in Germany. Within ESMO, he serves on the Guidelines Steering Committee.
More posts featuring Arndt Vogel.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023